ASI 2017* , ,
Presentations this author is a contributor to:
IL-15 dependent melanoma-resident CD8+ T cell numbers predict patient survival and outcome of anti-PD1 therapy (#332)
4:00 PM
Mainthan Palendira
Poster Session Two